Embecta Corp

NASDAQ EMBC

Download Data

Embecta Corp Capital Expenditure To Sales 3 year CAGR for the year ending September 30, 2023: -15.07%

Embecta Corp Capital Expenditure To Sales 3 year CAGR is -15.07% for the year ending September 30, 2023, a 49.92% change year over year. The capital expenditure ratio measures the proportion of a company's revenue allocated to capital expenditures. It is calculated by dividing capital expenditures by revenue. This ratio indicates the extent to which a company invests in long-term assets relative to its sales. A higher ratio suggests a higher level of investment in the expansion and improvement of the company's asset base. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Embecta Corp Capital Expenditure To Sales for the year ending September 30, 2022 was 2.12%, a -36.53% change year over year.
  • Embecta Corp Capital Expenditure To Sales for the year ending September 30, 2021 was 3.35%, a -13.27% change year over year.
  • Embecta Corp Capital Expenditure To Sales for the year ending September 30, 2020 was 3.86%, a -37.96% change year over year.
  • Embecta Corp Capital Expenditure To Sales for the year ending September 30, 2019 was 6.22%.
NASDAQ: EMBC

Embecta Corp

CEO Mr. Devdatt Kurdikar
IPO Date April 1, 2022
Location United States
Headquarters 300 Kimball Drive, Parsippany, NJ, United States, 07054
Employees 2,200
Sector Healthcare
Industry Medical instruments & supplies
Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Similar companies

ANGO

AngioDynamics Inc

NA

NA

AKYA

Akoya Biosciences Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email